Fibrostenotic Crohn's Disease

7 clinical trials · Condition

Record	Firm	Date
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease (NCT07683325)	Agomab Spain S.L.U.	2026-10-30
Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers (NCT07672574)	Agomab Spain S.L.U.	2026-07-20
A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease (NCT07428096)	Palisade Bio	2025-10-17
A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants (NCT07118878)	Agomab Spain S.L.U.	2025-08-06
A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups. (NCT06562361)	Antaros Medical	2024-08-01
STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease (NCT05843578)	Agomab Spain S.L.U.	2023-08-01
A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction (NCT05013385)	Boehringer Ingelheim	2021-11-09

Every clearance here is in the API, with alerts when new ones post.